cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes

Kevin Roehle, Li Qiang, Katherine S. Ventre, Daniel Heid, Lestat R. Ali, Patrick Lenehan, Max Heckler, Stephanie J. Crowley, Courtney T. Stump, Gabrielle Ro, Anže Godicelj, Aladdin M. Bhuiyan, Annan Yang, Maria Quiles del Rey, Tamara Biary, Adrienne M. Luoma, Patrick T. Bruck, Jana F. Tegethoff, Svenja L. Nopper, Jinyang LiKatelyn T. Byrne, Marc Pelletier, Kai W. Wucherpfennig, Ben Z. Stanger, James J. Akin, Joseph D. Mancias, Judith Agudo, Michael Dougan, Stephanie K. Dougan

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes'. Together they form a unique fingerprint.

Medicine & Life Sciences